Phoenix PharmaLabs Inc
OperatingHealthcare · Founded 2002
Addressing the opioid crisis by developing potent, safe, non-addictive painkillers.
Financials
FY2016–FY2023 (no data for FY2020, FY2021) · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inBlue bars are the pre-money valuation the company stated for a priced round. Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Share price over rounds
Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.
Cap table
Share counts as of Dec 31, 2022| Class | Outstanding | Votes / share | Share of total | Last price |
|---|---|---|---|---|
| Common Stock | 30,480,869 | — | 100.0% | $1.00Dec 2020 |
Shares outstanding over timein today's share terms
Sold to the crowd
- Reg CF · Oct 20181,315,432 shares at $0.81$1.1M
- Reg CF · Dec 20201,062,366 shares at $1.00$1.1M
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
5 peopleNames and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 2 of 8 annual reports (FY2018–FY2025)
Missing: 2018, 2020, 2021, 2022, 2024, 2025
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 15 filings on EDGAR- Form C-ARMay 7, 20240001755778-24-000001EDGAR
- Form C-UAug 6, 20210001669191-21-000768EDGAR
- Form C/AMay 10, 20210001669191-21-000518EDGAR
- Form C/AApr 19, 20210001669191-21-000399EDGAR
- Form C/AMar 22, 20210001669191-21-000296EDGAR
- Form C/AFeb 10, 20210001669191-21-000141EDGAR
- Form C/AJan 20, 20210001669191-21-000051EDGAR
- Form CDec 18, 20200001669191-20-000843EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.